Hemagen Diagnostics Revenue, Profits - HMGN Annual Income Statement

Add to My Stocks
$0.01 $0 (0%) HMGN stock closing price Oct 15, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Hemagen Diagnostics stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $4.04M for 2012 impacts the HMGN stock. Investors typically check year over year or quarter over quarter revenue growth. Revenue for year 2012 is $4.04M and has decreased from $5.14M year on year as is evident when you compare the latest figures in the latest Hemagen Diagnostics profit and loss statement with those of the prior corresponding period. Also see Hemagen Diagnostics assets and Hemagen Diagnostics free cash flow for a complete valuation of HMGN stock.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Oct - Sep20122011201020092008
Hemagen Diagnostics Revenues or Net Sales
Cost Of Goods Sold (COGS)2.42M3.18M2.86M3.34M3.6M
Hemagen Diagnostics Gross Profit
Research & Development Expense-----
Selling General & Admin Expense2M2.42M2.09M2.32M2.5M
Income Before Depreciation Depletion Amortization-0.43M-0.47M--0.34M-
Depreciation Depletion Amortization-----
Non Operating Income-----
Interest Expense-----
Hemagen Diagnostics Pretax Income
Provision for Income Taxes-----
Investment Gains Losses-----
Other Income-----
Income Before Extraordinaries & Disc Operations-0.9M-0.88M-0.15M-0.73M-0.37M
Extraordinary Items & Discontinued Operations----0.07M-
Hemagen Diagnostics Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS15.5M----
Average Shares used to compute Basic EPS15.5M----
Income Before Nonrecurring Items-0.91M----
Income from Nonrecurring Items-----
Hemagen Diagnostics Earnings Per Share Basic Net
Hemagen Diagnostics Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.06----
Preferred Dividends Acc Pd-----
Dividends Common-----
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.

Hemagen Diagnostics stock analysis involves checking at least a few of the important things like:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that HMGN stock has a topline or revenue of $4.04M for 2012 as per this Hemagen Diagnostics revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. HMGN stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the HMGN income statement, one can check the Hemagen Diagnostics historical stock prices to check how the price has moved with time.

Hemagen Diagnostics Income Statement - Key Financial Ratios